While the events controlling adipocyte differentiation have been largely explored, the mechanisms that direct proliferation and commitment of stem cells towards the adipogenic lineage remain unknown. Key information regarding the origin and the development of adipose tissue during embryogenesis is also lacking. Selection of embryonic stem (ES) cell-derived neuroepithelial progenitors shows that neuroectoderm, rather than mesoderm is a source of adipocytes. Furthermore, mapping of neural crest derivatives in transgenic mice demonstrates that during normal development a subset of adipocytes in the cranial region of the body originates from the neural crest. Various drugs have been tested on the early differentiation of ES cells. It appears that inhibitors of GSK3 behave as inhibitors of adipogenesis. Transcriptome of ES cells cultured under adipogenic conditions has been performed and function of relevant candidates in the first steps of adipogenesis will be discussed. In regard to humans, we have isolated mesenchymal stem (hMADS) cells from adipose tissue of young donors. In vivo hMADS cells are able to form bone after subcutaneous injection into nude mice. Transplantation into muscles of dystrophindeficient mdx mice results in substantial expression of human dystrophin. In vitro, hMADS cells differentiate into mature fat cells. Depending on culture conditions, hMADS cells can turn from white into functional brown adipocytes, highlighting the plasticity of adipocyte precursors. Finally, signalling pathways involved in proliferation and early differentiation of hMADS cells have been identified. These pathways may represent potential targets for controlling adipocyte precursor pool under conditions where fat tissue formation is impaired.
T1:RS1.2 PPAR family and adipogenesis

Kersten, S Wageningen University
The differentiation of pre-adipocyte precursor cells towards fully differentiated adipocytes is referred to as adipogenesis. In contrast, lipogenesis describes the process of fatty acid and subsequent triglyceride synthesis. Loss and gain of function experiments have indicated that both adipogenesis and lipogenesis are governed at the transcriptional level by the nuclear hormone receptor PPARγ. PPARγ is a ligand activated transcription factor that stimulates gene expression by binding to specific DNA sequence elements present in target genes. Numerous genes encoding a variety of different enzymes and transporters involved in glucose and lipid metabolism have been identified as direct target genes of PPARγ. Importantly, PPARγ is activated by synthetic agonists belonging to the insulin sensitizing thiazolidinediones. The major role of PPARγ in fat formation and storage is supported by the observation that treatment of type 2 diabetic patients with thiazolidinediones is generally associated with a moderate gain in fat mass. Several genetic variants of the PPARG gene are known. Interestingly, while rare mutations in the PPARG gene lead to a form of familial partial lipodystrophy characterised by altered fat distribution, muscular hypertrophy and severe insulin resistance, the common PPARG Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.
T1:RS1.3
Transcriptional control of hepatic fatty acid synthesis in liver: A role for ChREBP Postic, C., Denechaud, P., Robichon, C., Guinez, C., Behnamed, F., Dentin, R.,Girard, J.
Institute Cochin
Liver is responsible for the conversion of dietary carbohydrates into fatty acids, through de novo lipogenesis. Appropriate control of lipogenesis is crucial since excess fatty acid storage leads to hepatic steatosis and other related metabolic diseases. Carbohydrate Responsive Element Binding Protein (ChREBP) has recently emerged as a central regulator of glucose action and of lipid synthesis in liver. Using a RNAi approach in primary cultures of hepatocytes we have shown that ChREBP is required the induction of glycolytic (L-PK) and lipogenic genes (ACC, FAS) in response to glucose. In a physiopathological context, liver-specific inhibition of ChREBP, by decreasing lipogenic rates, improves hepatic steatosis and insulin resistance in obese ob/ob mice. Since ChREBP may appear as a potential therapeutic target, a better knowledge of the mechanisms involved in regulating its expression appears crucial. ChREBP is regulated at the transcriptional level by glucose but also requires posttraductional modifications for its activation. According to the current model, ChREBP is an inactive phosphorylated cytosolic protein (on under low glucose concentrations, while under high glucose concentrations, ChREBP undergoes dephosphorylation and is translocated into the nucleus to activate its target genes. Although ChREBP activity is dependent on its cellular localization the importance of the regulation of ChREBP by phosphorylationdephosphorylation needs to be established in a physiological context. We are also currently studying the respective roles of Liver X receptors (LXRs), nuclear receptors involved in the transcriptional control of lipogenesis, and glucose on ChREBP post-traductional activation in liver. Altogether, our results suggest that the stimulation of ChREBP by LXRs does not promote, in the absence of an active glucose flux, the dephosphorylation of the ChREBP protein on and its nuclear translocation.
T1:RS2.1 TNF-α α and inflammation
Nisoli, E.
University of Milan, Italy
Metabolic syndrome is defined by visceral fat accumulation, with insulin resistance or type 2 diabetes mellitus, hypertension, hypertriglyceridemia, and low high density lipoprotein cholesterol. It is now considered a chronic, lowgrade inflammation of different organs and tissues. Metabolic syndrome is a particularly challenging clinical condition to treat because of its complex molecular basis. Impaired cell metabolism has been suggested as a putative pathophysiological process leading to the different clinical features of the syndrome. We have reported that mitochondrial biogenesis and function are increased by nitric oxide in various cell types and tissues. Moreover, we found that endothelial nitric oxide synthase (eNOS) deficient mice (eNOS -/-) are affected by visceral fat accumulation, high blood pressure, hypertriglyceridemia, and insulin resistance with concomitant reduction of mitochondrial content in several tissues, including adipose tissue and skeletal muscle. Interestingly, increasing evidence suggest that the gaseous messanger might be considered a cellular metabolic sensor. This implies that a detective nitric oxide production might be linked to cell metabolism dysfunction. We have recently shown that both eNOS expression and mitochondrial biogenesis are down-regulated in metabolically active tissues, including white and brown adipose tissue and skeletal muscle of both genetically and high-fat feeding rodents affected by metabolic syndrome. TNF-α, which is overproduced in the adipose as well as muscle tissues of obese subjects, plays a significant role in these processes. Here we summarize our view on this issue and propose a novel pathophysiological hypothesis for metabolic syndrome with putative therapeutic implications, including that of increasing mitochondrial mass and function. 
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Adipokines and cardiovascular dysregulation
Fernández-Alfonso, M.
Universidad Complutense De Madrid
In the last years a paracrine role for periadventitial adipose tissue (PVAT) in the regulation of vascular function has been uncovered by several studies. Soltis and Cassis were the first to demonstrate that PVAT significantly attenuates vascular responsiveness of rat aortic rings to norepinephrine. More recent reports have confirmed the inhibitory action of PVAT on the contractile response to a variety of vasoconstrictors on rat aortic and mesenteric arteries, as well as on human thoracic arteries. The anti-contractile action is induced by a still undefined transferable factor released by periadventitial fat, called adipocyte-derived relaxing factor (ADRF). Its anticontractile effect seems to be mediated by different mechanisms depending on the type of vascular bed and species. PVAT is a source of leptin, which participates in the regulation of vascular tone. Vascular effects of leptin are the net result of two different actions: i) indirect vasoconstriction through stimulation of sympathetic activity at hypothalamic level, and ii) direct vasodilatation that depends on intact and functional endothelium through mechanisms that vary between different vascular beds. Moreover, PVAT also releases several vasoconstrictors. It expresses the components of the renin-angiotensin system and releases angiotensin II. Other factors with vasoactive effects, such as superoxide anion and inflammatory cytokines, have also been described. Changes in the amount of PVAT in different situations such as hypertension and obesity are related to an altered balance of vasoconstrictors and vasodilators, thus contributing to changes arterial blood pressure. The initial invasive processes lead to the proximity of cancer cells and adipocytes/pre-adipocytes. High matrix metalloproteinase 11/stromelysin-3 (MMP11/ST3) expression in primary tumors is associated with poor patient clinical outcome. Mouse tumor models show that MMP11 acts very early subsequent to cancer cell invasion. We have investigated the possible MMP11 involvement in cancer cell-adipocyte cross-talk at the human breast tumor invasive front. We show that cancer cells induce MMP11 expression by adjacent adipocytes. We demonstrate, in vitro and in vivo using MMP11-deficient mice, that MMP11 negatively regulates adipogenesis. Moreover, recombinant MMP11 reverts chemically-induced adipocyte differentiation of MMP11-deficient mouse embryonic fibroblasts. To date, most studies focusing on cancer cell-connective cell interactions have emphasized the role of fibroblasts, endothelial and inflammatory cells in fully-constituted tumor stroma that contains very few, if any, adipocytes. Our study points to the essential role of adipocytes in initial invasive steps and highlights the MMP11 participation. The origin of peritumoral fibroblasts, known to favor tumor progression, remains debated. Our results support the concept that pioneer invading cancer cells that induce the MMP11 production by proximal adipocytes/preadipocytes, initiate a vicious cycle leading to a default of adipocyte differentiation and the accumulation/maintenance of peritumoral fibroblast-like cells. These results constitute the first evidence implicating an MMP member in this process, and are of particular interest since epidemiological studies identify obesity as a major risk and/or a poor prognosis factor for cancer.
T1:RS3.1
Regulation of fatty acid utilisation
Frayn, KN University of Oxford, Oxford, UK Fatty acids typically constitute about 35% of the oxidative fuel used by people in Western societies. Fatty acid utilisation by tissues is regulated at many levels. It varies with nutritional state (generally it is highest in the fasting state, and during exercise, and reduced in the postprandial state). It also differs markedly amongst tissues. For instance, the brain oxidises almost no fat, whereas resting skeletal muscle derives around 95% of its energy requirements from fatty acid oxidation after an overnight fast. The regulation of fatty acid utilisation by a tissue such as skeletal muscle begins with events in the adipocyte. The supply of fatty acids from adipose tissue is highly regulated by nutritional state, mainly through the anti-lipolytic effect of insulin. Fatty acids are also delivered to cells as circulating triacylglycerol, in which case a key determinant of tissue fatty acid delivery is the enyme lipoprotein lipase. Cellular utilisation of fatty acids begins with transport across the cell membrane, a process that is still not fully understood, although the evidence continues to mount in favour of carrier-mediated diffusion. Within most cells there is metabolic partitioning of fatty acids between oxidation and glycerolipid synthesis (i.e. re-esterification). This is an important step for metabolic regulation via the malonyl-CoA-CPT1 mechanism. This mechanism provides the key link between the regulation of glucose and lipid metabolism. Altered fatty acid metabolic partitioning in liver and skeletal muscle in insulin resistance could be seen to underlie many of the adverse metabolic changes associated with this condition. Pennington Biomedical Research Center, Baton Rouge, LA, USA Biochemistry textbooks list adipose tissue and the liver as the sole sites of de novo lipogenesis in mammalian species. Skeletal muscle, an organ that oxidizes a large portion of the fatty acids in the diet also stores lipid in the form of intracellular triglycerides (IML). Triglyceride synthesis pathways are accepted as important to muscle metabolism but de novo lipogenesis is generally not thought to occur in skeletal muscle. That de novo lipogenesis might occur in skeletal muscle is supported by the observation that human skeletal muscle expresses all of the genes necessary to synthesize fatty acids from glucose [e.g. citrate lyase, ACC1, FAS]. These RNA signals are not merely contaminants from intermyofibrillar adipocytes as evidenced by their expression in cultured primary human skeletal muscle. Recent studies in our laboratory suggest that this pathway is functional in primary human skeletal muscle cultures and earlier experiments in rodents provide evidence for de novo lipogenesis in skeletal muscle. What is the functional role of de novo lipogenesis in skeletal muscle? There are several possibilities. First, de novo lipogenesis could be important in building IML stores under conditions of a high carbohydrate diet when glucose availability is high. Second, de novo lipogenesis, as a cataplerotic reaction, could relieve anaplerotic 'pressures' within the mitochondria and/or provide a sink for excess muscle energy stores. Lastly, if the newly synthesized lipids were oxidized [contemporaneously with synthesis] this would produce a thermogenic substrate cycle. Evidence for such a de novo lipogenesis -fatty acid oxidation cycle in skeletal muscle is strong and might serve as another mechanism to relieve energy excess within skeletal muscle or to generate heat. That this cycle is important to the overall functioning of an organism is not yet clear. However, demonstration of de novo lipogenesis in muscle suggests the possibility that manipulation of this system might be important in regulating energy balance, thermogenesis and type 2 diabetes. Adipose tissue (AT) is now recognized as an organ synthesizing and secreting numerous factors termed adipokines. So far, more than two hundred factors have been identified, acting in an autocrine, paracrine or endocrine way. Several adipokines have been shown to link obesity and insulin resistance or type 2 diabetes. Alteration of their levels in AT and in plasma, with obesity, can either improve or induce metabolic abnormalities. Thus, adipokines with insulin-mimetic and -sensitizing actions represent attractive targets for the treatment of obesity-induced metabolic diseases. In this context, the most beneficial adipokines were shown to bypass the insulin signaling through activation of the AMP-activated protein kinase. Thus, to clarify the mechanism of action and the physiological and patho-physiological significance of adipokines is a real challenge in obesity-related diseases research. However, attention must be paid to the fact that there is a multitude of adipokines with overlapping metabolic effects and an integrative view of their action is needed. A specific focus will be done on new adipokines that mimic insulin action in glucose or lipid metabolism, with a particular emphasis on the role of apelin. Apelin is a bioactive peptide, up-regulated in obese and hyperinsulinemic humans and mice. Recent data from our group showed that, in vivo in mice, apelin has a powerful glucose-lowering effect associated with enhanced glucose utilization in skeletal muscle and AT. In obese and insulin-resistant mice, apelin reduces glucose intolerance by improving glucose uptake in insulin-sensitive tissues underlying a relevant role of apelin in glucose metabolism. The relationship between early growth and an increased risk of type 2 diabetes and obesity in later life is well established. There is strong evidence from both human and animal studies that the early environment plays an important role and interest in this phenomenon has been prompted by studies showing that it is fetal and early post-natal growth patterns that have long-term consequences for health in adults. Maternal nutrition is a key determinant but smoking, alcohol consumption among other factors influence fetal growth and later adult disease risk. The precise molecular mechanisms underlying this relationship is not clear. What is becoming clear is that there are critical windows when nutrientgene-environmental interactions exert programming effects. One finding is that post-weaning catch-up growth in small for gestational age infants leads to a permanent obesity tendency. Several rodent models have been developed to explore this problem mechanistically and shown the influence of maternal dietary manipulation, fetal glucocorticoid overexposure and direct manipulation of fetal food intake on adult metabolic disease susceptibility.
Furthermore, it has been shown the supplementation of either or both offspring or dams with leptin during the 3 rd trimester and/or lactation permanently programmes the offspring to resist diet-induced obesity and insulin resistance in adult life. The mechanisms involved include reduced early weight gain, and changes in both hepatic and muscle metabolism, possibly as a result of epigenetic gene modification.
T1:RS4.2
Gut-brain axis. Based on our results and related data of literature we propose a new model explaining regulation of food intake. The central core of this model is the glucose monitoring (GM) network. Glucose-sensitive neurons have been discovered in the rat and monkey hypothalamus, the area postrema (AP), nucleus of the solitary tract (NTS), amygdala, globus pallidus, and orbitofrontal cortex (OBF). GM neurons are specific chemosensory cells monitoring neurochemicals of the local brain milieu and they receive humoral and viscerosensory information via the AP and the vagal nerve. Activities of GM neurons are influenced by electrophoretically applied insulin, glucagon, free fatty acid, opioids, different hormones, orexigenic and anorexigenic peptides. It is remarkable that orexigenic and anorexigenic peptides released in the gastrointestinal system act on the AP and influence the activity of afferent vagal fibers. These peptides are also localized in NTS and hypothalamic neurons which send their axons to different forebrain areas containing GM neurons. The central representation of taste and odor is highly overlapped with the GM network and majority of GM neurons exhibit remarkable activity changes to taste and odor stimulations. In the OBF reinforcing values of taste and odor are represented and texture and flavor of foods are evaluated. These evaluations converge with visual information related to food and are associated with the endogenous chemosensory information represented by the GM neuronal network. Thus, GM neurons play a distinct role integrating endogenous and exogenous information. Description of detailed cellular mechanisms of the GM network remains to be elucidated, however. Supported by ETT 315 and 317/2006, NKTH-OTKA K68431, RET-008/2005 MEDIPOLIS and  Many reports are present in the literature concerning the calorigenic effect of THs, with most of them aimed at identifying the molecular basis of this effect. However, at the moment the cellular/molecular mechanism(s) underlying these effects remain unsolved. In addition others THs derivatives are biologically active. Most of these compounds have interesting properties counteracting lipid accumulation, reducing cholesterol level and increasing lipid metabolism without cardiotoxic effects. In our laboratory we have investigated on the effects exerted by T2. When acutely injected, T2 has a more rapid effect on mitochondrial respiration than T3, the effect of the former being evident as early as 1 h after its injection, while that of T3 becomes evident only after 24 h. Moreover, the rapid effects of T2 are independent of protein synthesis (since they are also evident in the presence of cycloheximide), suggesting that they are due to a direct interaction with mitochondria or other cellular sites, whilst the effects of T3 are initiated via the nucleus. When administered to rats receiving a high-fat diet (HFD), T2 reduces both adiposity and body-weight gain without either inducing changes in T3 and T4 serum levels or affecting the HPT axis. This lack of a thyrotoxic effect was confirmed by the absence of any changes in the weights of thyroid gland and heart, or indeed in heart rate, in HFD rats following T2 treatment. Hopefully, further studies on basic mechanisms of such compounds will be harbingers of more knowledge and on their possible clinical application.
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International Journal of Obesity Live birth rates in obese patients with spontaneous pregnancies or following assisted reproductive technology (ART). This may be due to multiple factors. Miscarriages can occur more frequently in obese women, and those with a BMI >30 should be considered at high risk. Obesity is also associated with a higher risk of obstetric causes of maternal death and of anesthesia-related deaths. They have higher rates of complications in pregnancy, mainly in the third trimester, such as hypertension, preeclampsia, gestational diabetes (GD), thromboembolism, urinary tract infection, fetal macrosomia, preterm labour and delivery, etc. The negative impact of obesity can also be extended to fetal malformations. Moreover, children of obese mothers run a higher risk of intrauterine fetal death, head trauma, shoulder dystocia, brachial plexus lesions, fractures of the clavicle, and others. This can be further increased by obesityassociated GD or poorly controlled type I or II diabetes. Treatment of obesity should hopefully start before pregnancy, particularly in women wishing to plan their pregnancy. A decrease in BMI can often avoid miscarriages and may favour more adequate nutritional and metabolic environment for fetal development. In pregnant women, a lifestyle weight-controlling program should be started as soon as possible, aimed at maintaining body weight and avoiding further weight gain. Nutritional support should be adequate, and micronutrient intake should be carefully checked and supervised, with particular attention to iodine, folic acid and vitamin B, and foods with a low glycemic index should also be preferred. This is particularly important before ART, as shown in obese women with the PCOS.
T2:RS2.1 Special problems in childhood obesity management
Hamilton-Shield, J
Bristol Royal Hospital For Children & University Of Bristol
There are a number of confounding factors that can influence outcome in terms of weight management in childhood. One of the commonest is that of obesity on the background of special needs (physical or learning difficulties). 25% of children seen in the secondary care, obesity clinic in Bristol have significant learning or physical limitations. The difficulties may be related to genetic or metabolic complications associated with a particular disorder, or practical issues related to inappropriate eating or physical activity. Treatment options are limited in this context by failure of understanding of the issues relating to weight gain. Pharmacotherapy may be an option in adolescence but side-effects can limit the effectiveness of such interventions. As the prevalence of obesity in children with special needs is higher than amongst the general population this is an important issue that deserves more research. Amongst obese adolescents, additional co-morbidities influence attitudes and outcome. In Bristol, DSM-IV classified EDNOS (Binge Eating Disorder) was identified in 25% of our adolescents accounting for almost a fifth of male and a third of females patients. Polycystic ovarian syndrome is being increasingly recognised in adolescent obesity and additional therapies such as metformin and anti-androgens can enhance physiological well-being and improve weight loss. The increasing incidence of obesity related Type 2 diabetes in adolescence can also cause problems. Although standard therapy should include intensive lifestyle alterations with or without the additional use of metformin, paediatric diabetes clinics are almost exclusively centred on the management of Type 1 diabetes. The Counterweight Programme was developed based on the evidence based quality assessment model and piloted between 2000 -2005. Weight Management Advisers (WMAs, dietitians specialising in weight management) recruit and train practice staff to deliver a structured weight management pathway. Intervention consists of 6 structured appointments in 12 weeks, quarterly follow up for one year and then annual review. The primary outcome measure is weight loss from baseline. The key feature of Counterweight is WMA facilitating practice based implementation of the programme following initial staff training.
Outcomes from the pilot showed clinically beneficial weight loss of >5% in 31% and 32% of patients followed up at 12m and 24m respectively and improved with greater attendance. A health economic evaluation found the intervention to be dominant (i.e. cost savings > costs of providing with increased QALYs). This data provides a focus for discussion with health care commissioners around resource requirements for weight management intervention. Qualitative outcome measures from the pilot focussed on practitioner and patient experiences of the programme with learnings driving the following adjustments -1. A whole general practice meeting is held to agree roles, responsibilities and key messages 2. Materials have been revised and branded more clearly 3. Training for clinicians extended to three sessions with structured session plans. 4. Setting modest weight loss targets i.e. 5-10% from baseline, reasons for wishing to undertake weight management and lapse management are given stronger priority in session one 5. Consolidation of skills and knowledge and revision on weight maintenance are the focus for training session three 6. Competencies for buddy dietitians have been added and structure for buddy mentoring increased Evidence from the programme has led to Counterweight being commissioned by the Scottish government as part of the Keep Well Project, and in England eleven PCTs have commissioned Counterweight using Choosing Health resources. Programme expansion continues.
T2:RS1.2 Integrating weight management within psychiatry
B Waysfeld
Groupe De Reflexion Sur L'obesite Et Le Surpoids Traditionally, there has been some opposition between weight management and psychiatry. The former limits its frame of reference to the body and diet, the latter to mental difficulties. yet obese patients have been largely presented as not necessarily presenting more psychopathology than other subjects. However 30 to 40% of the overweight patients that we treat express suffering and psychological pain and therefore it raises the question for the psychiatrist: are these difficulties the causes or the consequences of being overweight? In terms of consequences, the stigmatisation of obese people can lead to negative self dialogue which affects self-esteem and can incite or aggravate a depressive condition, or oftentimes, an oversensitivity. Stigmatisation, as experienced by these subjects, can carry over to their stigmatising of certain foods. These foods are then often distinguished between good and bad, which encourages mental control over the act of eating, dissonance and cognitive restraint. All of the above aggravate usually a weight problem. The cognitive approach can be quite useful in these circumstances. In terms of causes, research has shown that genetics and psychology can link up in certain subjects, and that difficult emotions (depression, anxiety, anger) can favour eating disorders and excess weight. These can be, at times, adaptive symptoms whose removal should not be considered as urgent. Other areas, especially, the early mother-child relationship, cyclothymia, addiction, stress and consequences of alexithymia must also be considered when adapting the therapeutic approach. Finally, a psychosomatic itinerary specific to the numerous patients suffering with weight issues is becoming clearer: a constitutional tendency towards weight gain… perfectionism… …dietary restriction… thinness and nutritional deficiencies… eating disorders…overweight and obesity. The therapeutic approach will then vary according to those different stages. Introduction: The steady climb in the incidence of obesity in children and adolescents can be attributed to obesity prone lifestyle leading to chronic positive energy balance. The aim of the present review is to analyse the role of physical activity, the only component of total energy expenditure that can be voluntarily modified, in the prevention and management of obesity. Methods: Literature review Results: There is good evidence of the health related advantages of increased physical activity and disadvantages of physical inactivity in children and adolescents. There is an inverse relation between changes in physical activity levels and changes in BMI and adiposity. Recent studies have shown positive association between vigorous physical activity and cardiovascular fitness and a negative association between vigorous physical activity and fatness. Consequently physical activity and/or inactivity are reasonable targets for intervention programmes. However, when the effectiveness of intervention studies to reduce physical inactivity and to increase physical activity is investigated, then the results are quite disappointing. Conclusion: On the basis of evidence identified so far, the promotion of physical activity at the community-and society level has uncertain benefits. The essential components for success are unclear. A multifaceted, whole school approach might be promising. On balance, increasing physical activity in children is an attractive and non-restrictive approach to obesity prevention. To adopt this approach requires the support and involvement of many community sectors other than health.
T2:RS2.3 Pharmacological treatment in adolescence
Ziegler, O Service de Diabétologie -Nutrition CHU de Nancy, France, Université Henri Poincaré, Nancy, France
There is a considerable interest in the development of pharmacotherapeutic options for weight loss in overweight adolescents. The combination of severe obesity and co morbidities lower their quality of live drastically and could be considered as life threatening in the very long-term. The evidence suggests that comprehensive behavioural approaches may be unsuccessful. A few randomized, double-blind, placebo-controlled short-term clinical trials have evaluated whether or not orlistat or sibutramine are safe and effective, but only two 12-month trials have been published. Most trials have shown statistically significant reductions in BMI from baseline. Orlistat has no systemic effects which makes it an attractive candidate. The most frequently reported adverse effects are gastrointestinal and reduced concentrations of fat-soluble vitamins. Sibutramine seems to be more effective than orlistat. However it may be associated with elevated blood pressure and increased pulse rate. Importantly, a recent study suggests that sibutramine is well tolerated in this population and has minimal cardiovascular effects. Lastly, metformin has recently been evaluated for weight loss in very obese hyperinsulinaemic adolescents; small trials demonstrate modest reductions in BMI.
In conclusion, a careful risk-benefit analysis has to be performed, due to ethical concerns about any pharmacological treatment in this population. One can consider that at least some adolescents with severe obesity and alarming signs of complications could benefit from drug treatment. Extensive and carefully conducted longer term studies are needed to determine whether the weight loss is maintained and whether it translates into better clinical outcomes.
T2:RS3.1
Sustainable societal strategies for weight management: an ecological public health perspective Rayner G, Lang T City University, London, United Kingdom Whether focusing on food or physical activity, or on social, psychological, pharmacological or surgical levels of intervention, most thinking around obesity is framed within the dominant Western mode of individualised and consumerist action. This paper argues that an alternative ecological public health approach not only integrates currently fragmented thinking but offers clearer signals for public policy. The 'rule of rescue' predicts that societies with strongly individualistic ethics will focus on medical treatment or changing the lifestyles of individuals with weight problems, yet there is little evidence that such interventions have much -if any -success at the population level. Even when success occurs for individuals, the determinants of weight gain, principally environmental, remain unaltered. Conversely, ecological models in the natural and social sciences examine phenomena on a system-wide, rather than individualistic basis, and ecological principles underlie the thesis of the 'obesogenic society'. Ecological thinking also informs much conceptualisation within sustainable development strategy although ecological models in the social sciences, including the 'social determinants' field in public health, tend to vagueness or complexity, often with poor connections to natural ecology, on one hand, or to public policy mechanisms on the other. This paper will present the early conceptualisations of a project for the resolution of these dilemmas, building upon research on the public policy levers for managing population weight gain in the UK. The aim of the project is the aim to clarify, and then to mainstream, a model of ecological public health within the public health field which is applicable across different problem areas. Overcoming barriers to physical activity may be approached from an individual and a population perspective. The three dimensions of barriers are individual (skills, fitness, attitudes, motives, perceptions, self-efficacy, money, time etc.), social environment (family, friends, group to exercise with, etc.) and physical environment (access to sports facilities, easiness to move by walking or biking, etc.). The individual factors are obviously of crucial importance in individual counselling. Positive experiences from physical activity are a key issue. Therefore, in planning physical education at school, as well as physical activity programs for adults, positive experiences may be regarded even more important than any anticipated health effects of physical activity. Particularly obese individuals often dislike strenuous and competitive activities. A wide choice of physical activities increases the possibility for personal preferences. Moreover, by choosing from many alternatives an individual may find forms of physical activities which are compatible with his or her time commitments, financial status and personal identity. In the population approach, the barriers of the physical environment should be turned into possibilities and incentives. Urban planning and building strategies are important: it should be easy and rewarding to move around by walking and biking, and there should be attractive places for different kinds of physical activities and exercise in the local community. In conclusions, key points to manage barriers to physical activity are a) low threshold to start, b) individual preferences, c) social support, d) environmental possibilities.
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International Journal of Obesity A substantial deficit in energy balance is necessary to induce a clinically relevant weight loss in obese subjects. This can only realistically be achieved by an energy-restricted diet. Many weight loss programs, including low-energy diet (LED) providing only 800 kcal/day, effectively produce >10 % weight loss in >80 % of obese subjects. The amount of physical activity required to produce the same deficit is unrealistic in practice, but increased daily physical activity improves the prognosis for weight maintenance. Control visits are important in a weight maintenance phase of a trial, as are meetings with a dietician for support and 'feeling accountable to someone'. The major shortcomings of dietary therapy for weight maintenance are the barriers to change, e.g. feeling frustrated about and overwhelmed by the changes imposed by the many restrictions, or that the patients normally still live in an "obesogenic" environment. New trials have demonstrated that more diversified diets can be useful in weight maintenance and also that foods previously regarded as forbidden can be incorporated into the diet, e.g. dark chocolate, almonds, nuts, low-fat dairy products, lean meat, ad libitum fruit and vegetables, etc. Dietary intervention weight loss trials should also take the acceptability of the restricted diet, with reference to the local cuisine, preferences etc., into account. Nutrition interventions are a crucial component in formulating strategies for reducing the growing disease burden linked to obesity, but there is a need for high-quality trial data from which the economic performance of various nutrition interventions can be modelled.
T2:RS4.1
Obesity -all in the mind? The role of psychological interventions in obesity services Aim: Care pathways for morbid obesity cite 'psychosocial assessment' without detail. Surgical interventions are limited by postoperative complications. Our research portfolio suggests universal standards of psychobehavioural screening. Within an integrated obesity team we generated a database of 370 patients, and I present 4 studies. Methods: One psychiatrist (JFM) performed pre-and post-operative structured assessments (EDE, SCID). One surgeon (Mr. Fiennes, UCH) performed operations (2001) (2002) (2003) (2004) (2005) (2006) . Studies have been published at 1-5 year follow-up. Surgical outcomes included pouch dilatation, band erosion, surgical compliance, and failure to lose weight. Results: Study 1 (n=157, 1 year follow-up) demonstrated that surgical complications were predicted by binge eating (p=0.017), emotionally triggered eating (p=0.004), depression (p=0.026) and successful preoperative weight loss (p=0.035), but not compliance with orlistat, past trauma, history of bulimia or preoperative BMI. Study 2 (n=170) demonstrated that poor surgical compliance ('disengagers' & 'chaotic' compliers) was predicted by emotionally-triggered overeating (p=0.015), grazing (p=0.029), and viewing surgery as responsible for weight loss (p=0.029), but not depression or ED. Study 3 (n=37, 5 years follow-up) demonstrated poor surgical outcome predicted by postoperative binge eating or depression (p= 0.015), but not preoperative psychiatric variables. Study 4 (unpublished, n=370) suggests the concept of 'multi-impulsive eating disorder' be extended to obesity, with 1 in 10 patients presenting to the clinic with a cluster of interchangeable self-damaging behaviours. Conclusions: Obesity services need access to 'eating disorder' expertise. Subgroups are as complex to manage as anorexia nervosa. Psychological factors strongly predict outcomes, with disordered eating an attempt to modulate negative emotions. Screening may be necessary post-and pre-treatment, but sensitivities and specificities of screening are unknown, with further refinements required to inform rationing decisions. Preoperative evaluation of candidates for bariatric surgery: An interdisciplinary team is mandatory to evaluate candidates for bariatric surgery. This team consists of an internist with experience in nutritional and metabolic diseases, a dietician, a psychiatrist with experience in eating disorders, and a surgeon. The goal of such an assessment is to select eligible patients for a surgical intervention that suits them best and to detect patients that need further work up of their co-morbidities. Additional specialists may be needed (cardiologist, pneumologist, gastroenterologist, anaesthesiologist etc) to maximize the security of bariatric operations and minimize perioperative morbidity. It is important to rule out conditions that could be a contraindication for bariatric surgery. Another very important task of the preoperative management is to provide the candidate with all the necessary information about the consequences of each operation in the short and long run as well as to discuss pro's and con's of surgical therapy. Sufficient time for reconsidering should be offered. Follow-up: The success of any bariatric operation depends on a consistent follow-up regimen. The schedule and the extent of investigations depend on the type of operation. Adjustable banding patients need a schedule for band adjustments. Nutritional counselling is important to detect and correct any maladaptive eating behaviour. The frequency and extend of lab tests to detect malnutrition depend on the degree of malabsorbtion (micro-and/or macronutrients) in bypass-procedures. The team that is responsible for the follow-up should be familiar with complications typical for each operation type. The complications have to be detected at an early stage to initiate specific therapeutic steps in time. Insufficient weight loss may lead to the decision of re-operating a patient. Weight loss has to be measured and the evolution of co-morbidities monitored to adjust their medical treatment. A high follow-up rate is also needed for quality control purposes. There is growing evidence that obesity has an important impact on predisposing risk factors for coronary heart disease, namely dyslipidemia, glucose intolerance, insulin resistance and elevated blood pressure. It has been shown that an intentional weight reduction of 5-10 % may lead to a marked improvement in cardiovascular risk factors and a substantial reduction up to 20-25 % in co-morbidity. The 10% weight loss option has been reported to be associated with a reduction of 25-30 % of visceral fat, associated with an improvement of several metabolic disturbances. Although dietary approach and lifestyle adaptation remains the cornerstones of obesity therapy, long-term success is extremely disappointing -even after intensified therapeutic approaches, such as VLCD, dietary therapy, physical exercise and behavioural treatment. Over the last years, obesity research has been focused on the exploration of new biochemical pathways and on new pharmacological intervention potentials. Large-scale, long term studies have demonstrated that the use of pharmacological agents are able to induce significant weight loss (5-10%) in addition to dietary/physical activity approaches and important reduction of co-morbidities as well, fulfilling the targets of 20-30 % risk reduction. Characteristics of an ideal anti-obesity agent include safe molecules without major side effects, promoting a weight reduction in a dose dependent manner, having long lasting effects not leading to addictive properties and/or toxicity. Drugs working through peripheral mechanisms (lipase inhibition) or central active drugs (reuptake inhibition of neuro-amines at the neuronal synoptic cleft) are examples of a pharmacological approach that can qualify for such obesity management. New approaches for obesity treatment include blockade of the endocannabinoid system with rimonabant as the first selective CB1 blocker developed for the management of multiple cardiovascular risk factors. The Rimonabant In Overweight/Obesity (RIO) program (4 Phase III trials assessing the efficacy and safety of rimonabant in over 6600 overweight/obese patients) has shown that CB1 antagonism resulted in a significant reduction in both body weight and waist circumference compared with placebo as well as a substantial increase in HDL-cholesterol and significant reduction in triglyceride levels compared with placebo. Safety aspects of CB1 receptor blockers include gastro intestinal (nausea, vomiting) as well as neuro psychiatric (depression, mood disturbances) side effects. For this reason, prescription of rimonabant to patients with a past history of depression or being on anti depressive medication should be avoided. New approaches for obesity treatment include hormonal derivatives such as leptin analogues, its signalling peptides (CART, NPY antagonists …) and therapeutic molecules working at both peripheral and partially central level (CCK agonists, glucagon-like peptide etc.). To whom and when these drugs should be prescribed, depends on a thoroughly medical assessment of every patient on an individualized basis, also depending on the type and severity of obesity, its complications and previous attempts to lifestyle intervention. Also comorbidities, the presence of diabetes and mood disturbances will determine the choice of medication, which always has to be prescribed in combination with lifestyle intervention. Careful analysis of the overall risk and follow-up as part of global management, are of crucial importance to improve health, social well being and quality of life of obese patients treated with modern pharmacology. Several studies confirmed the tracking of overweight status from childhood to adulthood, particularly from the 7 years of age onward. In addition, very overweight children seem to increase their BMI levels with age and become morbidly obese in early adulthood. Parallel to the increase in obesity worldwhile, there is a rise in prevalence of type 2 diabetes mellitus (T2DM) in children and adolescents. Insulin resistance is strongly associated with obesity and is an early abnormality in the development of T2DM. Progression from insulin resistance to impaired glucose tolerance in obese youth is associated with a decrease in insulin sensitivity followed by a decline in insulin secretion. As the childhood population becomes increasingly overweight, T2DM may be expected to be even more common, particularly in adolescents with a strong positive family history. Clinically manifested complications are rare in this age group but their development starts in childhood and may progress more aggressively in early adulthood. If the obesity in adult life is heralded in the first decade of life, it is essential to recognize the risk factors of developing obesity in children. There is a clear inverse association between the social class in childhood and parental educational attainment. Greater BMI in children was associated with sedentary behavior and the number of TV watching hours as well as with high energy foods consumption. On the other hand, child's birth weight and breast feeding duration have been found to be rather controversial risk factors. Although the risk of obesity in adult life is increased ten folds if both parents are obese, parental obesity does not necessarily lead to obesity in their offspring. As treatment of obesity has low success rate, the efforts need to be focused on preventive strategies in children, particularly those coming from the families with several risk factors.
T3:RS1.2 Mechanisms of obesity-induced hypertension
Montani JP Dept. of Medicine/Physiology, University of Fribourg, Fribourg, Switzerland
The association between obesity and hypertension has been recognized for many decades. Numerous mechanisms have been postulated. However, much of our knowledge is based on correlations between body weight and various factors thought to increase blood pressure and the basic physiological mechanisms that link body weight and blood pressure are highly complex and not yet fully understood. Experimental models of obesity in animals, which can be studied sequentially before, during and after weight gain, have shown that vasoconstriction and sodium retention seem to be the cornerstones of the obesity-hypertension puzzle. No single factor explains obesity-induced hypertension, but many factors act together to promote vasoconstriction and sodium retention. Leptin, free fatty acids and insulin, whose levels are increased in obesity, combined with an activation of the renin-angiotensin system may act synergistically to stimulate sympathetic activity and vasoconstriction. In addition, obesity-induced insulin resistance and endothelial dysfunction may operate as amplifiers of the vasoconstrictor response. Finally, increased renal tubular reabsorption of sodium may also occur, caused by an increased renal sympathetic nerve activity, the direct effect of insulin on tubular cells, hyperactivity of the renin-angiotensin system and by an alteration of intrarenal physical forces. All enumerated factors act together toward a state of permanently elevated blood pressure. A better understanding of these mechanisms may lead to a better control and treatment of cardiovascular disorders.
T3:RS1.3
Cigarette smoking and the metabolic syndrome
Tonstad, S Ulleval University Hospital
Smoking cessation is associated with weight gain, however, population studies have shown that the amount of weight gain required to offset the benefits of stopping smoking 10 cigarettes/day is over 40 kg for a woman or man of average height. This is equivalent to over 15 BMI unites. Weight gain is attributable to a number of mechanisms. The net of effect of smoking cessation on the metabolic syndrome depends on a number of factors, including the amount of weight gain. While smoking cessation increases HDL cholesterol levels, the effects of cessation on waist circumference, triglyceride and glucose concentrations and blood pressure vary according to the amount of weight gain and other characteristics of the individual. During the past two decades some studies have shown that weight gain after smoking cessation appears to be greater than in studies conducted during the 1970s and 1980s. Smoking cessation should hold absolute priority in regard to disease prevention in overweight or obese individuals, above weight reduction. However, the issue of weight gain after smoking cessation needs to be addressed in the clinical setting. Some randomized controlled studies have shown that weight management in conjunction with smoking cessation programs increases continuous abstinence rates. Data showing that lifestyle intervention programs successfully reduce weight gain is sparse.
T3:RS2.1 Dyslipidemia and fatty liver
Feher, J.
2nd Department of Medicine, Semmelweis University, Budapest Dyslipidemia is part of the metabolic syndrome, which consists of obesity, type 2 diabetes mellitus, hypertension and hyperlipidemia as well as nonalcoholic fatty liver disease. This metabolic disorder is one of the most frequent disease accompanied by numerous complications. Obesity, type 2 diabetes mellitus, dyslipidemia, and hypertension contribute to risk for liver disease and to disease progression. Patients have a high risk for cardiovascular morbidity and mortality, mediated by early atherosclerosis. Non-alcoholic fatty liver disease refers to a wide spectrum of liver damage, ranging from simple steatosis to non-alcoholic steatohepatitis, advanced fibrosis and cirrhosis or even hepatocellular cancer. The more components of the metabolic syndrome are present, and the more severe they are, the higher the likelihood of this transition is to happen. An important factor is the massive influx of fat and free fatty acids into the liver. Excessively activated fat metabolism is associated with the release in various cell compartments of free radicals (reactive oxygen species), which are cytotoxic. This oxidative stress plays the most important role in the progression of the disease. The damaged cells express cytokines, which results in inflammation, cell death and fibrogenesis. The therapy consists of correspondent life style, blood lipid and sugar control, scavengers and antioxidants (silymarin, ursodeoxycholic acid, metadoxine). Atorvastatin and losartan are proved to be efficient in the treatment of dyslipidemia-and hypertension-associated non alcoholic steatohepatitis by bettering both biochemical parameters and steatosis or necroinflammation.
Abstracts
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International Journal of Obesity Adipose tissue is a highly active organ, not only storing calories as triglycerides, but also secreting a large variety of proteins, including cytokines, chemokines and hormone-like factors, such as leptin, adiponectin and resistin. Intriguingly, many, if not most, of these adiposederived proteins have dual actions: cytokines have not only immunomodulatory functions, but also act as systemic or auto-/paracrine regulators of metabolism, while proteins such as leptin and adiponectin are not only regulators of metabolism, but also inflammation. One of the major proteins secreted by adipocytes is the anti-inflammatory cytokine IL-1Ra, which is markedly increased in the serum of obese patients and appears to contribute to the acquired resistance to insulin and leptin. Furthermore, the production of pro-atherogenic and angiogenic proteins by adipose tissue is of particular interest, since their local secretion, e.g. by perivascular adipose depots, provides novel mechanistic links between obesity and the associated vascular complications. In summary, adipose tissue s a potent modulator of systemic and local inflammation, thereby regulating metabolic processes, which are involved in the pathogenesis of type 2 diabetes and its complications. Most health behaviour change theories and traditional approaches to patient education are viewed as means of influencing the behaviour of patients to "get" them to the follow the recommendations of health professionals. In addition, visits to health professionals often focus exclusively on improving clinical parameters and fail to address the patient's concerns about having and managing diabetes. The empowerment approach on the other hand is grounded in, and honours patients' lived experience of having diabetes and their right to make diabetes self-management decisions. We will examine empowerment as a patient-cantered, collaborative approach to diabetes care and education designed to facilitate patients' self-directed behaviour change, psychosocial adaptation and improved quality of life. We will consider the reasons why the empowerment approach emphasizes addressing problems and concerns deemed important by the patient. Our responsibility as health professionals is to ensure that our patients are making selfmanagement decisions that are informed by an understanding of the health implications of those decisions and an awareness of what approach to diabetes self-management is best suited to their priorities and resources. Finally, will examine the rationale for each step of the empowerment selfdirected behaviour change protocol. Therapeutic patient education is a patient-centred approach, focused on patients' needs, resources, values and strategies. It allows patients to improve their knowledge and skills not only concerning their illness, but also their treatment. It brings a better quality of life, a greater therapeutic compliance and a reduction in complications. The most difficult part of therapeutic patient education occurs when patients must change their behaviour. Motivational interviewing approaches contribute greatly here and allow both the preparation and support of patients during progressive "step by step" change. The work on resistance to change is fundamental, and ambivalence when faced with the choice of a new way of life must be measured, discussed and negotiated. Along with an empathic attitude and principles involved in the motivational interviewing, there are also strategies and even tools available. The first objective is to foster the emergence of a discourse of change, and to do this, it is beneficial to make use of four techniques. The first is asking open questions instead of the usual closed ones. Secondly, the therapist valorises patients' efforts, their personal efficacy and self-esteem. Thirdly, during therapeutic education the therapist makes use of reflective listening with empathic reformulations and paraphrasing which reflect patients' legitimate feelings. Lastly, the health care professional must summarise the interview's various stages to allow patients to follow the progress of the explanations of their ambivalence In conclusion, health care professionals teach, inform, train, negotiate with, motivate and accompany patients in the long-term follow-up of their illness.
T4:RS1.3 Relapse management
Rössner, S Karolinska University Hospital, Huddinge, Stockholm, Sweden
Weight loss improves practically all risk factors associated with obesity. With weight regain these benefits are lost. Most people can lose weight, but fewer can maintain that weight loss for longer time periods. Our 1985 long-term study, using conventional tools of diet, exercise and behavioural modification is an early example of the fact that even by standard methods long-term weight loss maintenance can actually be achieved. Drugs workas long as they are taken. Weight cycling has been regarded as a risk for metabolic complications, but the general opinion of today would suggest that the psychological side effects of repeated failures are more important than the somatic effects. It has been argued that whatever success can be achieved will take place with the first 6 months and that it is a waste of resources to continue afterwards. This approach would help some but leave out those for whom a consistent behaviour change takes much longer time. On the other hand, it has been well demonstrated that early success is one of the most important predictors of long-term outcome. Data from the National Weight Control Registry suggest that if 10% weight loss maintenance is accepted as a goal, 20% of overweight/obese subjects may actually achieve success. Behavioural changes, selfmonitoring, a low fat diet and high level of physical activity all predict long-term success. Maintained losses >2-5 years greatly increase further long-term success; weight control becomes easier with time.
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T4:RS2.1 In recent years, patient education for self management of obesity and chronic diseases has undergone considerable changes, becoming no longer directive and not only informative as in the past, but aiming to improved patients' self-awareness, decision-making and motivation, encouraging and generating changes. On this line, a novel approach has been adopted, more and more sensitive to the patients' needs as expressed by narrative and self writing, stemming from a pedagogic knowledge which is embedded in the paradigm of complexity. In this new perspective, research was able to show the progress made by focusing on self-care behaviours, and on the patients' quality of life. In the fields of obesity and associated cardiovascular risk factors, many results have been obtained including healthy eating, smoking cessation and medium/long term increase of daily physical activity. Also the quality of life was improved thanks to ad hoc education, aiming at increasing patients' empowerment and psycho-social coping skills, and this was regularly followed by improved behaviours and better biomedical outcomes. The exclusive use of quantitative research, however, has been criticized in this field belonging to human sciences as well as to medicine. On this line, promising perspectives for future research come from the association of qualitative research methods, which have been shown to integrate very effectively with quantitative methods in chronic disease care. Moreover the human qualities of educators, such as interpersonal skills, empathy and the ability to establish a therapeutic alliance have seldom been considered and deserve evaluation, ideally by integrated qualitative and quantitative methods.
Optimising patient education
T4:RS2.2
Technology enhanced care for persons with eating disorders. The lack of progress in preventing the growth of obesity in developed countries, via individual targeted interventions has shifted research and practice to examine broader social and environmental determinants.
Recently new studies have attempted to assess the relative contribution of individual, social and environmental variables, particularly the built environment. Systematic reviews of primary studies examining the relationship between the built environment, physical activity and diet have identified inconsistent associations between access to physical activity facilities and food outlets and restaurants and specific obesity related behaviors. Explanations for these results may lie in (i) fewer studies examining the effect of the built environment and diet behaviors compared to physical activity, (ii) methodological challenges in assessing the exposure variables of the built environment which are specific to the overall and sub components of physical activity and diet behaviors, (iii) assessing the behaviors themselves, (iv) development of appropriate theoretical models to systematically test the complexity of the relationship between people, places and behaviors. The majority of studies focus on USA environments and may not be generalisable to other countries. The interaction between individual, communities, their behaviors and social and built environments may be too complex to capture in simple cross section studies. Multi-disciplinary research with mixed methods may provide a better understanding of this phenomenon.
T5:RS1.2 How to assess diet in public health
Summerbell, CD University of Teesside, Middlesbrough, England, UK
Currently, large-scale group or population dietary surveys rely on selfreported accounts of dietary intake through diary records, frequency and recall questionnaires. However, these methods are often labour intensive for researchers, and time consuming and monotonous for participants to complete. There is a need to develop valid, reliable, low-burden, simple, cost-effective and engaging methods of accurately assessing dietary intake at the group or population level. This presentation will assess and compare the usefulness of diary records, frequency and recall questionnaires for the purpose of assessing diet in public health. Particular consideration will be given to which of these methods are best suited to different groups with the population, e.g. age groups, vulnerable groups. This presentation will also describe the development, evaluation and future potential of novel methods of diet assessment. Web-based tools, which exploit the popularity, privacy and engagement of the computer interface (in addition to the possibility of data linkage), could make a substantial contribution to future public health dietary monitoring and research.
Abstracts
S12
International Journal of Obesity Obesity is now commonly defined in adults as a BMI > 30 kg/m². Particularly for health promotion purposes BMI may be replaced by classification based on waist circumference but also there specific classifications for different ethnic groups may be necessary. The prevalence of obesity in established market economies (Europe, USA, Canada, Australia etc) varies greatly but a weighed estimate suggests an average prevalence in the order of 15-20%. The prevalence in these countries generally shows increasing trends over time.
Obesity is also relatively common in Latin America but much less so in sub-Saharan Africa and Asia where the majority of the world population lives. Nevertheless obesity rates are increasing there as well and, more importantly, rates of diabetes increase even faster particularly in Asian countries. The risks of type 2 diabetes mellitus in these countries tend to increase sharply at levels of BMI. An increasing proportion of patients with cardiovascular disease are obese and this should be taken into account in their management. The imbalance between declining energy expenditure due to physical inactivity and high energy in the diet (excess calories whether from sugar, starches or fat) is the main determinant of the obesity epidemic. Increasing physical activity, plus reducing intakes of foods high in fat and foods and drinks high in sugars, can prevent unhealthy weight gain. Taking these simple goals to concrete action requires major social and environmental changes in order to effectively promote and support healthier choices at the individual level. To achieve best results in preventing nutrition-related chronic diseases, strategies and policies should fully recognize the essential role of both diet and physical activity in determining good nutrition and optimal health. Policies and programmes must address the need for change at the individual level as well as the modifications in society and the environment to make healthier choices accessible and preferable. In communities, districts and nations in which widespread, integrated interventions have taken place, dramatic decreases in NCD-related death and disability have occurred. Successes have come about where people have acknowledged that the unnecessary premature deaths that occur in their community are largely preventable and have empowered themselves and their civic representatives to create health-supporting environments. This has been achieved most successfully by establishing a working relationship between communities and governments; through enabling legislation and local initiatives affecting schools and the workplace; involving food producers and processing industry. Beyond the rhetoric, this epidemic can be halted -the demand for action must come from those affected. The solution is in our hands.
T5:RS2.2
Overweight and obesity and the burden of disease and quality of life
SG Wannamethee
Royal Free and University College Medical School, London, UK
The prevalence of obesity (BMI >30) has reached epidemic levels in western societies. Overweight and obesity constitute a major public health problem because of the associated increased risk of coronary heart disease (CHD), stroke, type 2 diabetes, hypertension, dyslipidemia, musculoskeletal disorders and some cancers. Both the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) 4 and WHO 5 now recommend 25 kg/m 2 as the upper limit of ideal weight for all adults regardless of age. However the importance of overweight and obesity as predictors of mortality in elderly people (>65 years) has been controversial, with several studies failing to show any relation between overweight/obesity and mortality. The distribution of body fat (visceral fat) is an important determinant of metabolic abnormalities e.g dyslipidimia, hypertension, possibly more so than the degree of excess weight as measured by the body mass index. Other markers such as waist circumference (WC) or muscle mass measurements may be a better anthropometric guide to metabolic risk factor status and obesity-related health risks. Despite definitional and assessment issues, a growing body of evidence has also linked obesity to impairments in health-related quality of life. In this review we assess the burden of disease, cardiovascular risk factors and disability associated with overweight and obesity. We assess whether the current WHO weight guidelines are appropriate in the elderly and whether other measures such as the waist circumference may provide a better tool for identifying obesity related metabolic abnormalities and mortality risk particularly in older men.
T5:RS2.3 Cost implications, under and over estimations
Visscher, TLS 1,2 1 Vrije Universiteit-Windesheim, Zwolle, The Netherlands 2 EASO taskforce on prevention and public health, London, United Kingdom Obesity is now high on both political and scientific agendas, due to its impact on public health. Amongst the outcome measures that are easily understood by policy makers, are cost estimates of obesity. Purpose of this paper is to review cost estimates in the literature and to elucidate potential determinants for under-or overestimations of these cost-estimates. Different cost-estimates are compared, taking into account different prevalence rates of obesity, and different age-and educational categories. Different outcome measures affecting costs have been considered. The majority of studies present direct health care costs of overweight and obesity based on prevalence rates and relative risks. Estimates vary between 1 and 6% in Europe, and between 6 and 10% in the US, due to a higher prevalence rate of obesity in the US than in Europe. Fewer studies present indirect obesity related cost estimates of inproductivity, varying between 6 and 10%. Cost estimates are mainly based on samples of the general population. While cost estimations do not take into account measures as daily-adjusted life-years or unhealthy life-years, recent literature suggests that the relation between obesity and disabilities is becoming more important and will thus increase obesity-related costs. Future studies should take into account age-and socio-economic status in cost estimates. The lack of cost estimates taking into account an increase in unhealthy life-years in the obese, leads to the conclusion that presented cost estimates are likely to be under-estimated.
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T5:RS3.2
Innovation and rigour in the evaluation of child public health obesity prevention interventions: striving to understand whether, how and for whom interventions are effective.
Waters, E
McCaughey Centre, School of Population Health, University Of Melbourne
The challenge for public health interventions is to construct evaluations of either research or public health programs that are going to be used in decision making to make an impact on population health improvements. Debates rage regarding the appropriate amount of evaluation funding necessary to construct a useful evaluation, but the more important questions are those around evaluation rigour, appropriate methods and processes for useful information, and the integration of qualitative and quantitative methods. In the context of childhood obesity prevention strategies, it is essential that a focus remain on the outcomes -particularly whilst we are still are yet to identify types of programs that are going to make a sustainable impact and may be transferable to varying contexts. The evidence base will be significantly strengthened through evaluations that are rigorously designed and theoretically underpinned, employ mixed methods, capture process, impact and outcomes, engage stakeholders, and result in meaningful results for participants and users. This presentation will provide illustrations of innovative yet rigorous evaluation strategies that can be employed in childhood obesity prevention programs, and specify the components which need care in their application and interpretation.
T5:RS3.3 Social Marketing
Holmes, C Most observers would agree that the commercial marketing activities of the food industry and physical inactivity industries are culpable, to some degree, for unhealthy weight gain in populations. Agreeing this is the case is to accept that these techniques, predicated as they are on market research approaches, must be capable of influencing individual behaviour. Might these techniques have something to offer in understanding how to support people in improving dietary behaviour and increasing physical activity? This presentation shares the process and outcomes of 18-months work, for the United Kingdom's Department of Health, in bringing together both academic knowledge and market research techniques to provide insight into the emotional relationship of young families with food and physical (in)activity. The objective is to inform the development of healthy weight 'promotion' strategies and also the issues and potential mechanisms through which families might engage with the issue of unhealthy weight gain. The approach has been a highly pragmatic one that attempts to recognise the challenges presented by the paucity of evidence in this public health arena. Given the scale, growth and implications of unhealthy weight, it reflects a strong belief in the need for "practice based evidence" and "evidence based practice". Carrying out the work has highlighted the challenges of bringing together these two research 'churches' across the respective professions and the sphere of policy development. However, it has also has suggested the possible opportunities that might exist for tackling unhealthy weight gain if this could be achieved. In the past 30 years the prevalence of obesity worldwide has increased dramatically in adults, children and adolescents. These individuals have a significant risk of having metabolic and cardiovascular complications related to their obesity even from adolescence. Several hospital-based in-patient trials have been conducted to try to help obese adults lose weight and sustain the weight loss over a long period of time with success only in short-term weight loss. Community Intervention Programs in adults providing nutritional guidance, exercise and behavioral modification have been more successful in long-term weight loss but with still only 30% of the adults maintaining a 5% weight loss over two years. Because of these discouraging results in adults many Community Intervention Programs have been aimed at children and adolescents with varying but more optimistic results. The most successful Community Obesity Intervention Programs are school-based and they actively influence dietary and increased physical activity behavior not just knowledge of these behaviors. They involve the school staff, the parents and the students in school-time and after-school programs. Some programs also provide a "buddy system" where the older students act as "peer teachers" for the younger students by eating healthy lunches together and mutual involvement in games and sports.
In conclusion, more research is needed to provide adults with more successful obesity intervention programs. In children and adolescents the Community Intervention Programs need to start from kindergarten and be sustained through high school in order to have a significant impact in reducing the worldwide obesity epidemic. Community interventions that produce lasting improvements in health behaviors are rare. Why is change so hard to sustain? What will it take to make healthy behaviors part of the social norm? Interventions often stimulate short term change due to unsustainably large investments in personnel, facilities, messaging and other infrastructure. As the funding diminishes so go the healthy behaviors. Initiatives are designed as special "programs", which implies temporary, rather than as new business models. Interventions die out because they lack a persistent incentive structure that motivates people to "do the right thing" at key behavior choice moments throughout the day. The benefits of adopting healthy behaviors are "time discounted", meaning people don't experience a benefit immediately. Time-deferred benefits have a hard time competing with the "here and now" benefits of less healthy choices like consuming high calorie food or resting watching television. Furthermore, "bad" behaviors tend to provide the best value (convenience and money for benefit) and are heavily promoted, giving them a bigger "share of mind" than healthier choices. So, how do we make community interventions "built to last"? First, we need to develop a more compelling incentive structure that gives people immediate rewards for choosing healthier behaviors-in effect, we need a new business model. Second, we need to better leverage the social "connectors" within communities to accelerate adoption of change by more people. Finally, we need to involve a broader range of stakeholders in communities in order to make healthy behaviors part of "business as usual" in daily life.
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International Journal of Obesity The goal of this synthesis research study was to develop best practice recommendations with a focus on population health. Therefore, although based on a systematic approach to finding, selecting and critically appraising programs addressing prevention and treatment of childhood obesity -this synthesis review is unique in being much broader and more inclusive compared with previous systematic reviews. A comprehensive and wide search of 18 medical/ academic databases, covering the years 1982-2003, and 213 Internet websites (for grey literature) was conducted. Key informant surveys were undertaken to ensure important studies were included. The results from the library databases (13, 158 hits), the Internet search and key informant surveys were reduced to a review of 982 reports of which 500 were selected for critical appraisal. The appraisal approach developed to distinguish which of these reports should be included in the synthesis was innovative in that it included scoring strategies from four different perspectives: population health, immigrant health and programme development/ evaluation. This resulted in the identification of a total of 158 articles (representing 147 programmes) for inclusion in the synthesis. The synthesis process included identification of gaps, an analysis and summary of programme development and programme effectiveness to enable conclusions to be drawn and recommendations to be made. Engagement in physical activity emerged as a critical intervention from among the myriad of different interventions tackling obesity and related disease risk in children that were considered. In addition, a holistic approach -where nutrition interventions were combined with physical activity, behaviour modification and family involvement, was identified as being most promising in terms of making a positive impact on outcomes particularly in primary school and community settings. This presentation describes the approach used in this synthesis research and the overall findings.
